Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3055% below fair value
$1.09−0.15 (-11.74%)
Close on Nov 18, 2026Market cap $5.01MP/E –Yield –
Biomerica price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Biomerica's price to book ratio was 1.9× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.8× to 6.4×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | +0.5 |
| 2025 | Dec 31, 2025 | 1.4× | +0.4 |
| 2024 | Dec 31, 2024 | 0.9× | −1.0 |
| 2023 | Dec 29, 2023 | 2.0× | −3.4 |
| 2022 | Dec 30, 2022 | 5.4× | −0.1 |
| 2021 | Dec 31, 2021 | 5.5× | +0.9 |
| 2020 | Dec 31, 2020 | 4.7× | −3.5 |
| 2019 | Dec 31, 2019 | 8.2× | +4.4 |
| 2018 | Dec 31, 2018 | 3.7× | −3.7 |
| 2017 | Dec 29, 2017 | 7.4× | +3.8 |
| 2016 | Dec 30, 2016 | 3.6× | +1.9 |
| 2015 | Dec 31, 2015 | 1.8× | +0.6 |
| 2014 | Dec 31, 2014 | 1.2× | +0.2 |
| 2013 | Dec 31, 2013 | 1.0× | −0.1 |
| 2012 | Dec 31, 2012 | 1.1× | +0.4 |
| 2011 | Dec 30, 2011 | 0.7× | – |
See a number that looks wrong?